Houston Consensus Conference on Testing for Helicobacter pylori Infection in the United States

被引:199
作者
El-Serag, Hashem B. [1 ,2 ]
Kao, John Y. [3 ]
Kanwal, Fasiha [1 ,2 ,4 ]
Gilger, Mark [5 ,6 ]
LoVecchio, Frank [7 ]
Moss, Steven F. [8 ]
Crowe, Sheila [9 ]
Elfant, Adam [10 ]
Haas, Thomas [11 ]
Hapke, Ronald J. [12 ]
Graham, David Y. [1 ,2 ]
机构
[1] Michael E DeBakey VA Med Ctr, Dept Med, Houston, TX USA
[2] Baylor Coll Med, Dept Med, Houston, TX 77030 USA
[3] Univ Michigan Med, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI USA
[4] Ctr Innovat Qual Effectiveness & Safety, Houston, TX USA
[5] Childrens Hosp San Antonio, Baylor Coll Med, San Antonio, TX USA
[6] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA
[7] Univ Arizona, Dept Med, Tucson, AZ USA
[8] Brown Univ, Providence, RI 02912 USA
[9] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA
[10] Rowan Univ, Cooper Med Sch, Camden, NJ USA
[11] Mercy Hlth Syst, Dept Pathol, Janesville, WI USA
[12] Legacy Emanuel Med Ctr, Dept Gastroenterol, Northwest Gastroenterol Clin, Portland, OR USA
关键词
Bacterial Infection; Urea Breath Test; Stool Antigen Test; Resistance; GASTRIC-CANCER-PATIENTS; PEPTIC-ULCER; ERADICATION THERAPY; ATROPHIC GASTRITIS; LYMPHOID-TISSUE; RISK; MANAGEMENT; EPIDEMIOLOGY; OMEPRAZOLE; DISEASE;
D O I
10.1016/j.cgh.2018.03.013
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Despite guidelines for detection and treatment of Helicobacter pylori infection, recommendations to test patients before and after therapy are commonly not followed in the United States. At the Houston Consensus Conference, 11 experts on management of adult and pediatric patients with H pylori, from different geographic regions of the United States, met to discuss key factors in diagnosis of H pylori infection, including identification of appropriate patients for testing, effects of antibiotic susceptibility on testing and treatment, appropriate methods for confirmation of infection and eradication, and relevant health system considerations. The experts divided into groups that used a modified Delphi panel approach to assess appropriate patients for testing, testing for antibiotic susceptibility and treatment, and test methods and confirmation of eradication. The quality of evidence and strength of recommendations were evaluated using the GRADE system. The results of the individual workshops were presented for a final consensus vote by all panel members. After the Expert Consensus Development meeting, the conclusions were validated by a separate panel of gastroenterologists, who assessed their level of agreement with each of the 29 statements developed at the Expert Consensus Development. The final recommendations are provided, on the basis of the best available evidence, and provide consensus statements with supporting literature to implement testing for H pylori infection at health care systems across the United States.
引用
收藏
页码:992 / +
页数:17
相关论文
共 80 条
  • [1] Can eradication therapy for Helicobacter pylori really improve the thrombocytopenia in idiopathic thrombocytopenic purpura?: Our experience and a literature review
    Ando, K
    Shimamoto, T
    Tauchi, T
    Ito, Y
    Kuriyama, Y
    Gotoh, A
    Miyazawa, K
    Kimura, Y
    Kawai, T
    Ohyashiki, K
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2003, 77 (03) : 239 - 244
  • [2] GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations
    Andrews, Jeff
    Guyatt, Gordon
    Oxman, Andrew D.
    Alderson, Phil
    Dahm, Philipp
    Falck-Ytter, Yngve
    Nasser, Mona
    Meerpohl, Joerg
    Post, Piet N.
    Kunz, Regina
    Brozek, Jan
    Vist, Gunn
    Rind, David
    Akl, Elie A.
    Schuenemann, Holger J.
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2013, 66 (07) : 719 - 725
  • [3] [Anonymous], 2001, RAND UCLA APPROPRIAT
  • [4] Helicobacter pylori Eradication to Eliminate Gastric Cancer: The Japanese Strategy
    Asaka, Masahiro
    Mabe, Katsuhiro
    Matsushima, Rumiko
    Tsuda, Momoko
    [J]. GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2015, 44 (03) : 639 - +
  • [5] High-Dose Extended-Release Lansoprazole (Dexlansoprazole) and Amoxicillin Dual Therapy for Helicobacter pylori Infections
    Attumi, Taraq A.
    Graham, David Y.
    [J]. HELICOBACTER, 2014, 19 (04) : 319 - 322
  • [6] Follow-up Testing After Treatment of Helicobacter Pylori Infections: Cautions, Caveats, and Recommendations
    Attumi, Taraq A.
    Graham, David Y.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2011, 9 (05) : 373 - 375
  • [7] Helicobacter gastroduodenitis: A serious infectious disease - Antibiotic treatment may prevent deaths in the decades ahead
    Axon, A
    Forman, D
    [J]. BRITISH MEDICAL JOURNAL, 1997, 314 (7092) : 1430 - 1431
  • [8] The individual and joint contributions of Helicobacter pylori infection and family history to the risk for peptic ulcer disease
    Brenner, H
    Rothenbacher, D
    Bode, G
    Adler, G
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (04) : 1124 - 1127
  • [9] Effects of Helicobacter pylori Infection on Long-term Risk of Peptic Ulcer Bleeding in Low-Dose Aspirin Users
    Chan, Francis K. L.
    Ching, Jessica Y. L.
    Suen, Bing Yee
    Tse, Yee Kit
    Wu, Justin C. Y.
    Sung, Joseph J. Y.
    [J]. GASTROENTEROLOGY, 2013, 144 (03) : 528 - 535
  • [10] American college of gastroenterology guideline on the management of Helicobacter pylori infection
    Chey, William D.
    Wong, Benjamin C. Y.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 (08) : 1808 - 1825